Switch to:
Also traded in: Canada, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.71
HLTH's Cash to Debt is ranked higher than
67% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.31 vs. HLTH: 0.71 )
Ranked among companies with meaningful Cash to Debt only.
HLTH' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 4.45 Max: No Debt
Current: 0.71
Equity to Asset 0.48
HLTH's Equity to Asset is ranked higher than
55% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HLTH: 0.48 )
Ranked among companies with meaningful Equity to Asset only.
HLTH' s Equity to Asset Range Over the Past 10 Years
Min: -0.73  Med: 0.38 Max: 0.81
Current: 0.48
-0.73
0.81
Interest Coverage 15.77
HLTH's Interest Coverage is ranked higher than
63% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 9.36 vs. HLTH: 15.77 )
Ranked among companies with meaningful Interest Coverage only.
HLTH' s Interest Coverage Range Over the Past 10 Years
Min: 47.44  Med: 10000.00 Max: 9999.99
Current: 15.77
47.44
9999.99
F-Score: 3
Z-Score: 1.98
M-Score: 0.03
WACC vs ROIC
12.66%
29.01%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 11.19
HLTH's Operating margin (%) is ranked higher than
67% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. HLTH: 11.19 )
Ranked among companies with meaningful Operating margin (%) only.
HLTH' s Operating margin (%) Range Over the Past 10 Years
Min: -176.32  Med: 13.86 Max: 64.77
Current: 11.19
-176.32
64.77
Net-margin (%) 4.45
HLTH's Net-margin (%) is ranked higher than
51% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. HLTH: 4.45 )
Ranked among companies with meaningful Net-margin (%) only.
HLTH' s Net-margin (%) Range Over the Past 10 Years
Min: -243.59  Med: -27.75 Max: 9.6
Current: 4.45
-243.59
9.6
ROE (%) 15.33
HLTH's ROE (%) is ranked higher than
72% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 9.24 vs. HLTH: 15.33 )
Ranked among companies with meaningful ROE (%) only.
HLTH' s ROE (%) Range Over the Past 10 Years
Min: -169.82  Med: -31.16 Max: 33.26
Current: 15.33
-169.82
33.26
ROA (%) 6.90
HLTH's ROA (%) is ranked higher than
67% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. HLTH: 6.90 )
Ranked among companies with meaningful ROA (%) only.
HLTH' s ROA (%) Range Over the Past 10 Years
Min: -114.87  Med: -20.90 Max: 10.37
Current: 6.9
-114.87
10.37
ROC (Joel Greenblatt) (%) 73.50
HLTH's ROC (Joel Greenblatt) (%) is ranked higher than
85% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 20.18 vs. HLTH: 73.50 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HLTH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -576.55  Med: 57.40 Max: 266.35
Current: 73.5
-576.55
266.35
Revenue Growth (3Y)(%) 66.50
HLTH's Revenue Growth (3Y)(%) is ranked higher than
98% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. HLTH: 66.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HLTH' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -51.3  Med: -27.25 Max: 187.4
Current: 66.5
-51.3
187.4
» HLTH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

HLTH Guru Trades in

HLTH Guru Trades in

Q2 2015

HLTH Guru Trades in Q2 2015

Chuck Royce 292,300 sh (New)
Jim Simons 20,200 sh (New)
» More
Q3 2015

HLTH Guru Trades in Q3 2015

Chuck Royce 366,600 sh (+25.42%)
Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with HLTH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 28.20
HLTH's P/E(ttm) is ranked lower than
55% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 27.90 vs. HLTH: 28.20 )
Ranked among companies with meaningful P/E(ttm) only.
HLTH' s P/E(ttm) Range Over the Past 10 Years
Min: 3.71  Med: 30.22 Max: 1403.27
Current: 28.2
3.71
1403.27
Forward P/E 4.76
HLTH's Forward P/E is ranked higher than
97% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 16.75 vs. HLTH: 4.76 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 29.40
HLTH's PE(NRI) is ranked lower than
58% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 24.85 vs. HLTH: 29.40 )
Ranked among companies with meaningful PE(NRI) only.
HLTH' s PE(NRI) Range Over the Past 10 Years
Min: 3.71  Med: 31.23 Max: 4040.73
Current: 29.4
3.71
4040.73
P/B 2.12
HLTH's P/B is ranked higher than
62% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 2.53 vs. HLTH: 2.12 )
Ranked among companies with meaningful P/B only.
HLTH' s P/B Range Over the Past 10 Years
Min: 0.26  Med: 2.50 Max: 13.7
Current: 2.12
0.26
13.7
P/S 0.93
HLTH's P/S is ranked higher than
64% of the 301 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. HLTH: 0.93 )
Ranked among companies with meaningful P/S only.
HLTH' s P/S Range Over the Past 10 Years
Min: 0.17  Med: 0.79 Max: 62.5
Current: 0.93
0.17
62.5
PFCF 318.00
HLTH's PFCF is ranked lower than
96% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 20.37 vs. HLTH: 318.00 )
Ranked among companies with meaningful PFCF only.
HLTH' s PFCF Range Over the Past 10 Years
Min: 0.4  Med: 4.55 Max: 723
Current: 318
0.4
723
POCF 53.00
HLTH's POCF is ranked lower than
95% of the 275 Companies
in the Global Medical Care industry.

( Industry Median: 14.09 vs. HLTH: 53.00 )
Ranked among companies with meaningful POCF only.
HLTH' s POCF Range Over the Past 10 Years
Min: 0.39  Med: 6.13 Max: 120.5
Current: 53
0.39
120.5
EV-to-EBIT 7.31
HLTH's EV-to-EBIT is ranked higher than
97% of the 290 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HLTH: 7.31 )
Ranked among companies with meaningful EV-to-EBIT only.
HLTH' s EV-to-EBIT Range Over the Past 10 Years
Min: -2305.2  Med: 3.65 Max: 144.3
Current: 7.31
-2305.2
144.3
EV-to-EBITDA 6.41
HLTH's EV-to-EBITDA is ranked higher than
93% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 12.05 vs. HLTH: 6.41 )
Ranked among companies with meaningful EV-to-EBITDA only.
HLTH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -37.8  Med: 3.50 Max: 119
Current: 6.41
-37.8
119
Current Ratio 2.75
HLTH's Current Ratio is ranked higher than
84% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.33 vs. HLTH: 2.75 )
Ranked among companies with meaningful Current Ratio only.
HLTH' s Current Ratio Range Over the Past 10 Years
Min: 0.56  Med: 2.79 Max: 6.55
Current: 2.75
0.56
6.55
Quick Ratio 2.64
HLTH's Quick Ratio is ranked higher than
85% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. HLTH: 2.64 )
Ranked among companies with meaningful Quick Ratio only.
HLTH' s Quick Ratio Range Over the Past 10 Years
Min: 0.53  Med: 2.62 Max: 6.08
Current: 2.64
0.53
6.08
Days Inventory 517.34
HLTH's Days Inventory is ranked lower than
99% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 16.67 vs. HLTH: 517.34 )
Ranked among companies with meaningful Days Inventory only.
HLTH' s Days Inventory Range Over the Past 10 Years
Min: 16.82  Med: 42.26 Max: 1941.4
Current: 517.34
16.82
1941.4
Days Sales Outstanding 123.65
HLTH's Days Sales Outstanding is ranked lower than
90% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 45.70 vs. HLTH: 123.65 )
Ranked among companies with meaningful Days Sales Outstanding only.
HLTH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.97  Med: 71.41 Max: 183.16
Current: 123.65
30.97
183.16
Days Payable 3.00
HLTH's Days Payable is ranked lower than
96% of the 144 Companies
in the Global Medical Care industry.

( Industry Median: 42.47 vs. HLTH: 3.00 )
Ranked among companies with meaningful Days Payable only.
HLTH' s Days Payable Range Over the Past 10 Years
Min: 34.18  Med: 53.75 Max: 19118.01
Current: 3
34.18
19118.01

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 79.50
HLTH's Price/Net Current Asset Value is ranked lower than
88% of the 64 Companies
in the Global Medical Care industry.

( Industry Median: 11.25 vs. HLTH: 79.50 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
HLTH' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 3.82  Med: 14.00 Max: 212.25
Current: 79.5
3.82
212.25
Price/Tangible Book 6.36
HLTH's Price/Tangible Book is ranked lower than
72% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 3.66 vs. HLTH: 6.36 )
Ranked among companies with meaningful Price/Tangible Book only.
HLTH' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.59  Med: 6.11 Max: 91
Current: 6.36
1.59
91
Price/Projected FCF 2.41
HLTH's Price/Projected FCF is ranked lower than
67% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HLTH: 2.41 )
Ranked among companies with meaningful Price/Projected FCF only.
HLTH' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.05  Med: 0.23 Max: 5.27
Current: 2.41
0.05
5.27
Price/Median PS Value 1.19
HLTH's Price/Median PS Value is ranked higher than
92% of the 300 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. HLTH: 1.19 )
Ranked among companies with meaningful Price/Median PS Value only.
HLTH' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.29  Med: 1.05 Max: 65.23
Current: 1.19
0.29
65.23
Price/Graham Number 2.89
HLTH's Price/Graham Number is ranked higher than
75% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 2.51 vs. HLTH: 2.89 )
Ranked among companies with meaningful Price/Graham Number only.
HLTH' s Price/Graham Number Range Over the Past 10 Years
Min: 0.1  Med: 1.26 Max: 7.86
Current: 2.89
0.1
7.86
Earnings Yield (Greenblatt) (%) 13.70
HLTH's Earnings Yield (Greenblatt) (%) is ranked higher than
96% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. HLTH: 13.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HLTH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.7  Med: 22.40 Max: 118.4
Current: 13.7
0.7
118.4

More Statistics

Revenue(Mil) $179
EPS $ 0.08
Short Percentage of Float9.31%
52-Week Range $1.82 - 9.34
Shares Outstanding(Mil)73.64

Analyst Estimate

Dec15 Dec16
Revenue(Mil) 318 462
EPS($) 0.36 0.68
EPS without NRI($) 0.36 0.68

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Traded in other countries:NHC.Canada, NH1.Germany,
Northstar Healthcare, Inc. partners with the physicians in the development and management of ambulatory surgery centres in the United States. It manages an ambulatory surgery centre in Dallas and two pain management clinics in Houston.
» More Articles for AMEX:HLTH

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in... Feb 05 2016
StoneCastle's Bruce Campbell Interviewed by The Life Sciences Report Feb 04 2016
HLTH INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Nobilis Health... Feb 03 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Nobilis Health Corp. of Class... Feb 01 2016
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of... Jan 28 2016
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving... Jan 25 2016
Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Nobilis... Jan 25 2016
Lifshitz & Miller Law Firm Announces Investigation of GoPro Inc., Iconix Brand Group, Inland Real... Jan 22 2016
Hagens Berman Advises Nobilis Health Corp. (NYSE MKT:HLTH) Investors of March 21, 2016 Lead... Jan 22 2016
CORRECTING and REPLACING: Pomerantz Law Firm Announces the Filing of a Class Action Against Nobilis... Jan 21 2016
IMPORTANT SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action... Jan 21 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Nobilis Health Corp. of Pendency of... Jan 21 2016
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Nobilis... Jan 20 2016
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Nobilis... Jan 20 2016
Nobilis Health Corp. Updates Full Year 2015 Guidance Jan 19 2016
Pomerantz Law Firm Announces the Filing of a Class Action Against Nobilis Health Corp. and Certain... Jan 19 2016
NOBILIS HEALTH CORP. Financials Jan 16 2016
NOBILIS HEALTH CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 14 2016
SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against Nobilis Health... Jan 13 2016
Robbins Arroyo LLP Is Investigating the Officers and Directors of Nobilis Health Corp. (HLTH) on... Jan 13 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK